Pharmacological inhibition of autophagy by HCQ ameliorates obesity, hyperlipidaemia, hepatic steatosis and insulin resistance phenotypes in Acss3–/– mice. The gene discussed is ACSS3; the disease is obesity due to melanocortin 4 receptor deficiency.